Daudén E - Search Results

1

The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics.

Christophers E, Barker JN, Griffiths CE, Daudén E, Milligan G, Molta C, Sato R, Boggs R. Christophers E, et al. Among authors: dauden e. J Eur Acad Dermatol Venereol. 2010 May;24(5):548-54. doi: 10.1111/j.1468-3083.2009.03463.x. Epub 2009 Oct 23. J Eur Acad Dermatol Venereol. 2010. PMID: 19874432

2

Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.

Ho VC, Griffiths CE, Berth-Jones J, Papp KA, Vanaclocha F, Dauden E, Beard A, Puvanarajan L, Paul C. Ho VC, et al. Among authors: dauden e. J Am Acad Dermatol. 2001 Apr;44(4):643-51. doi: 10.1067/mjd.2001.112400. J Am Acad Dermatol. 2001. PMID: 11260540 Clinical Trial.

3

Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.

Pedraz J, Daudén E, Delgado-Jiménez Y, García-Río I, García-Díez A. Pedraz J, et al. Among authors: dauden e. J Eur Acad Dermatol Venereol. 2006 Jul;20(6):702-6. doi: 10.1111/j.1468-3083.2006.01577.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16836499 Clinical Trial.

4

A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: phase II).

Carrascosa JM, Pujol R, Daudén E, Hernanz-Hermosa JM, Bordas X, Smandia JA, Ferrándiz C. Carrascosa JM, et al. Among authors: dauden e. J Eur Acad Dermatol Venereol. 2006 Aug;20(7):840-5. doi: 10.1111/j.1468-3083.2006.01659.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16898908

5

Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus.

Boehncke WH, Brasie RA, Barker J, Chimenti S, Daudén E, de Rie M, Dubertret L, Giannetti A, Katsambas A, Kragballe K, Naeyaert JM, Ortonne JP, Peyrí J, Prinz JC, Saurat JH, Strohal R, van de Kerkhof P, Sterry W; European Dermatology Expert Group. Boehncke WH, et al. Among authors: dauden e. J Eur Acad Dermatol Venereol. 2006 Sep;20(8):988-98. doi: 10.1111/j.1468-3083.2006.01707.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16922950

6

Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensus.

Reich K, Griffiths C, Barker J, Chimenti S, Daudén E, Giannetti A, Gniadecki R, Katsambas A, Langley R, Mrowietz U, Ogilvie A, Ortonne JP, Reider N, Saurat JH. Reich K, et al. Among authors: dauden e. Dermatology. 2008;217(3):268-75. doi: 10.1159/000149970. Epub 2008 Aug 6. Dermatology. 2008. PMID: 18685261 Free article.

7

Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study.

Daudén E, Griffiths CE, Ortonne JP, Kragballe K, Molta CT, Robertson D, Pedersen R, Estojak J, Boggs R. Daudén E, et al. J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1374-82. doi: 10.1111/j.1468-3083.2009.03321.x. Epub 2009 Jun 26. J Eur Acad Dermatol Venereol. 2009. PMID: 19563497 Clinical Trial.

8

Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts.

Dubertret L, Chimenti S, Christophers E, Daudén E, de Rie M, Griffiths CE, Kragballe K, Ståhle M, Stingl G. Dubertret L, et al. Among authors: dauden e. Br J Dermatol. 2009 Aug;161 Suppl 2:1-30. doi: 10.1111/j.1365-2133.2009.09173.x. Br J Dermatol. 2009. PMID: 19594542 No abstract available.

9

Definition of treatment goals for moderate to severe psoriasis: a European consensus.

Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Daudén E, Gisondi P, Iversen L, Kemény L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N. Mrowietz U, et al. Among authors: dauden e. Arch Dermatol Res. 2011 Jan;303(1):1-10. doi: 10.1007/s00403-010-1080-1. Epub 2010 Sep 21. Arch Dermatol Res. 2011. PMID: 20857129 Free PMC article.

10

Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients.

Sánchez-Moya AI, Dauden E. Sánchez-Moya AI, et al. Among authors: dauden e. J Eur Acad Dermatol Venereol. 2011 Jun;25(6):730-3. doi: 10.1111/j.1468-3083.2010.03836.x. Epub 2010 Sep 14. J Eur Acad Dermatol Venereol. 2011. PMID: 21564322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page